| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.8 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |